LAMIVUDINE

Substance profile for UNII 2T8Q726O95, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII: 2T8Q726O95
Preferred term: LAMIVUDINE
Registry number: 134678-17-4
Ingredient type: INGREDIENT SUBSTANCE
Molecular formula: C8H11N3O3S

Chemical And Database Identifiers#

InChIKey: JTEGQNOMFQHVDC-NKWVEPMBSA-N
SMILES: NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
RxCUI: 68244
PubChem: 60825
NCIt: C1471
INN ID: 6908

Open Chemistry Sources#

Source, Identifier, Link table
Source	Identifier	Link
PubChem Compound	60825	https://pubchem.ncbi.nlm.nih.gov/compound/60825
PubChem InChIKey Search	JTEGQNOMFQHVDC-NKWVEPMBSA-N	https://pubchem.ncbi.nlm.nih.gov/#query=JTEGQNOMFQHVDC-NKWVEPMBSA-N
RxNorm	68244	https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=68244
NCI Thesaurus	C1471	https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1471
FDA Substance Registration System	2T8Q726O95	https://precision.fda.gov/uniisearch/srs/unii/2T8Q726O95

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets 150 mg and 300 mg, for oral use Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets 150 mg and 300 mg, for oral use Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPZICOM ® (abacavir sulfate and lamivudine) Tablets	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPZICOM ® (abacavir sulfate and lamivudine) Tablets	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPZICOM ® (abacavir sulfate and lamivudine) Tablets	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPZICOM ® (abacavir sulfate and lamivudine) Tablets	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (lamivudine and zidovudine) tablet, film coated	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (lamivudine and zidovudine) tablet, film coated	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1000
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]	1000
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	15
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	15
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [APOTEX CORP.]	15
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [APOTEX CORP.]	15
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR HBV (LAMIVUDINE) TABLET, FILM COATED EPIVIR HBV (LAMIVUDINE) SOLUTION [GLAXOSMITHKLINE LLC]	14
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR HBV (LAMIVUDINE) TABLET, FILM COATED EPIVIR HBV (LAMIVUDINE) SOLUTION [GLAXOSMITHKLINE LLC]	14
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED EPIVIR (LAMIVUDINE) SOLUTION [VIIV HEALTHCARE COMPANY]	11
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED EPIVIR (LAMIVUDINE) SOLUTION [VIIV HEALTHCARE COMPANY]	11
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	10
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	10
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]	7
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]	7
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET [LUPIN PHARMACEUTICALS, INC.]	6
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET [LUPIN PHARMACEUTICALS, INC.]	6
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE TABLET [LUPIN PHARMACEUTICALS, INC.]	5
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE TABLET [LUPIN PHARMACEUTICALS, INC.]	5
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	5
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	5
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]	4
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]	4
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
lamivudine	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE SOLUTION [SILARX PHARMACEUTICALS, INC]	4
Lamivudine	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE SOLUTION [SILARX PHARMACEUTICALS, INC]	4
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	3
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	3
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	3
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	3
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	3
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	3
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [UNIT DOSE SERVICES]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [UNIT DOSE SERVICES]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [APOTEX CORP.]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [APOTEX CORP.]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [PRASCO LABORATORIES]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [PRASCO LABORATORIES]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	DIRECT RX (LAMIVUDINE ZIDOVUDINE) TABLET [DIRECT RX]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	DIRECT RX (LAMIVUDINE ZIDOVUDINE) TABLET [DIRECT RX]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	EPIVIR (LAMIVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [AVKARE, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [AVKARE, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET [STRIDES ARCOLAB LIMITED]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET [STRIDES ARCOLAB LIMITED]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [EXELAN PHARMACEUTICALS INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [EXELAN PHARMACEUTICALS INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [REMEDYREPACK INC. ]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [ST MARYS MEDICAL PARK PHARMACY]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [ST MARYS MEDICAL PARK PHARMACY]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AVPAK]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AVPAK]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]	1
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [GOLDEN STATE MEDICAL SUPPLY, INC.]	1

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date
LAMIVUDINE	Major Pharmaceuticals	2026-03-13
Lamivudine and Zidovudine	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit V	2026-03-12
Abacavir and Lamivudine	Laurus Labs Limited	2026-01-12
Lamivudine	Strides Pharma Science Limited	2026-01-05
lamivudine	Chartwell Govermental & Specialty RX, LLC.	2026-01-02
lamivudine	Chartwell RX, LLC	2025-12-30
LAMIVUDINE	Golden State Medical Supply, Inc.	2025-11-24
doravirine, lamivudine, and tenofovir disoproxil fumarate	Merck Sharp & Dohme LLC	2025-10-29
dolutegravir sodium and lamivudine	ViiV Healthcare Company	2025-10-29
abacavir sulfate, dolutegravir sodium, lamivudine	ViiV Healthcare Company	2025-10-29
LAMIVUDINE and ZIDOVUDINE	PD-Rx Pharmaceuticals, Inc.	2025-10-17
LAMIVUDINE	Apotex Corp. \| Apotex Inc.	2025-09-19
Lamivudine	Golden State Medical Supply, Inc.	2025-08-12
Lamivudine	Apotex Corp. \| Apotex Inc.	2025-06-17
ABACAVIR and LAMIVUDINE	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit V	2025-05-31
Abacavir and Lamivudine	Macleods Pharmaceuticals Limited	2025-03-03
Lamivudine	Coupler LLC \| Strides Pharma Science Limited	2025-02-06
lamivudine	Camber Pharmaceuticals, Inc. \| Annora Pharma Private Limited	2025-01-09
Lamivudine	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit V	2025-01-09
Lamivudine	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit V	2025-01-09
Lamivudine	American Health Packaging	2024-09-16
lamivudine	ViiV Healthcare Company	2024-08-15
Lamivudine and Zidovudine	Aurobindo Pharma Limited	2024-05-24
Abacavir and Lamivudine	Aurobindo Pharma Limited	2024-05-19
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	Laurus Labs Limited \| Laurus Labs Limited (VSP2)	2024-05-07
Lamivudine	Aurobindo Pharma Limited	2024-04-29
Lamivudine	Rising Pharma Holdings, Inc. \| Aurobindo Pharma Limited	2024-04-16
Lamivudine	Aurobindo Pharma Limited	2024-04-16
Lamivudine and Zidovudine	Bryant Ranch Prepack	2024-04-05
Lamivudine	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2024-01-03
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	Laurus Labs Limited \| Laurus Labs Limited (VSP2)	2023-11-15
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2023-10-31
Abacavir and Lamivudine	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2023-10-30
lamivudine and zidovudine	ViiV Healthcare Company	2023-08-22
Lamivudine and Zidovudine	Macleods Pharmaceuticals Limited	2023-07-13
LAMIVUDINE and ZIDOVUDINE	Bryant Ranch Prepack	2023-03-29
LAMIVUDINE AND ZIDOVUDINE	XLCare Pharmaceuticals, Inc \| Ascent pharmaceuticals, Inc	2023-01-16
Lamivudine	Macleods Pharmaceuticals Limited	2022-12-01
LAMIVUDINE and ZIDOVUDINE	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit V \| Hetero Labs Limited Unit III	2022-09-16
Abacavir and Lamivudine	Cipla USA Inc. \| Cipla Ltd. Patalganga unit II	2022-01-18
Lamivudine and Tenofovir Disoproxil Fumarate	Viatris Specialty LLC	2021-02-15
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	Viatris Specialty LLC	2019-10-15
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	Viatris Specialty LLC	2019-10-15
Lamivudine and Zidovudine	Exelan Pharmaceuticals Inc. \| Ascent Pharmaceuticals Inc.	2019-01-01
Lamivudine	Ingenus Pharmaceuticals, LLC \| Arise Pharmaceuticals LLC \| Appco Pharma LLC	2018-12-24
Lamivudine and Zidovudine	Shanghai Desano Bio-Pharmaceutical Co., Ltd.	2018-05-18
Lamivudine	Centaur Pharmaceuticals Private Limited	2017-06-22
Lamivudine Zidovudine	Direct Rx	2016-06-22
Lamivudine	Marlex Pharmaceuticals Inc	2016-01-31
abacavir sulfate, lamivudine, and zidovudine	State of Florida DOH Central Pharmacy	2014-04-24
lamivudine	State of Florida DOH Central Pharmacy	2014-03-03
lamivudine and zidovudine	State of Florida DOH Central Pharmacy	2014-02-27
LAMIVUDINE	State of Florida DOH Central Pharmacy	2013-09-12
Lamivudine and Zidovudine	H.J. Harkins Company, Inc.	2012-06-25
Lamivudine and Zidovudine	Rebel Distributors Corp	2012-04-04
lamivudine and zidovudine	H.J. Harkins Company, Inc.	2012-02-02
lamivudine and zidovudine	Rebel Distributors Corp	2010-09-24
lamivudine	Rebel Distributors Corp	2010-09-24
abacavir sulfate and lamivudine	Physicians Total Care, Inc.	2010-07-01
abacavir sulfate and lamivudine	State of Florida DOH Central Pharmacy	2010-05-11
lamivudine	Physicians Total Care, Inc.	2010-04-14
lamivudine	State of Florida DOH Central Pharmacy	2010-04-13
lamivudine, zidovudine	Stat Rx USA	2009-10-27

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category
0904-6583	LAMIVUDINE	lamivudine	Major Pharmaceuticals	ANDA
31722-001	lamivudine	lamivudine	Camber Pharmaceuticals, Inc.	ANDA
31722-752	Lamivudine	Lamivudine	Camber Pharmaceuticals, Inc.	ANDA
31722-753	Lamivudine	Lamivudine	Camber Pharmaceuticals, Inc.	ANDA
31722-754	Lamivudine	Lamivudine	Camber Pharmaceuticals, Inc.	ANDA
33342-001	Lamivudine	Lamivudine	Macleods Pharmaceuticals Limited	ANDA
33342-002	Lamivudine	Lamivudine	Macleods Pharmaceuticals Limited	ANDA
49702-203	EPIVIR	lamivudine	ViiV Healthcare Company	NDA
49702-204	EPIVIR	lamivudine	ViiV Healthcare Company	NDA
49702-205	EPIVIR	lamivudine	ViiV Healthcare Company	NDA
50742-623	Lamivudine	Lamivudine	Ingenus Pharmaceuticals, LLC	ANDA
50742-624	Lamivudine	Lamivudine	Ingenus Pharmaceuticals, LLC	ANDA
51407-866	Lamivudine	Lamivudine	Golden State Medical Supply, Inc.	ANDA
57237-274	Lamivudine	Lamivudine	Rising Pharma Holdings, Inc.	ANDA
60429-353	LAMIVUDINE	lamivudine	Golden State Medical Supply, Inc.	ANDA
60429-354	LAMIVUDINE	lamivudine	Golden State Medical Supply, Inc.	ANDA
60505-3250	Lamivudine	Lamivudine	Apotex Corp.	ANDA
60505-3251	LAMIVUDINE	lamivudine	Apotex Corp.	ANDA
60505-3252	LAMIVUDINE	lamivudine	Apotex Corp.	ANDA
60687-720	Lamivudine	Lamivudine	American Health Packaging	ANDA
62135-706	lamivudine	lamivudine oral	Chartwell RX, LLC	ANDA
64380-710	Lamivudine	Lamivudine	Strides Pharma Science Limited	ANDA
64380-711	Lamivudine	Lamivudine	Strides Pharma Science Limited	ANDA
65862-025	Lamivudine	Lamivudine	Aurobindo Pharma Limited	ANDA
65862-026	Lamivudine	Lamivudine	Aurobindo Pharma Limited	ANDA
65862-055	Lamivudine	Lamivudine	Aurobindo Pharma Limited	ANDA
67046-1459	Lamivudine	Lamivudine	Coupler LLC	ANDA
68180-602	Lamivudine	Lamivudine	Lupin Pharmaceuticals, Inc.	ANDA
68999-706	lamivudine	lamivudine oral	Chartwell Govermental & Specialty RX, LLC.	ANDA
0173-0662	EPIVIR	lamivudine	GlaxoSmithKline LLC	NDA
0173-0663	EPIVIR	lamivudine	GlaxoSmithKline LLC	NDA
10135-605	Lamivudine	Lamivudine	Marlex Pharmaceuticals Inc	ANDA
21695-367	EPIVIR	lamivudine	Rebel Distributors Corp	NDA
50090-0550	EPIVIR	lamivudine	A-S Medication Solutions	NDA
50268-459	Lamivudine	Lamivudine	AvPAK	ANDA
50268-460	Lamivudine	Lamivudine	AvPAK	ANDA
51293-832	Lamivudine	Lamivudine	ECI Pharmaceuticals LLC	ANDA
53808-0245	EPIVIR	lamivudine	State of Florida DOH Central Pharmacy	NDA
53808-0246	EPIVIR	lamivudine	State of Florida DOH Central Pharmacy	NDA
53808-0843	LAMIVUDINE	lamivudine	State of Florida DOH Central Pharmacy	ANDA
53808-0844	LAMIVUDINE	lamivudine	State of Florida DOH Central Pharmacy	ANDA
53808-0893	EPIVIR	lamivudine	State of Florida DOH Central Pharmacy	NDA
54838-566	Lamivudine	Lamivudine	Lannett Company, Inc.	ANDA

LAMIVUDINE

Substance Identity#

Chemical And Database Identifiers#

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Related DailyMed Labels#

Related NDC Products#